NCT02682693 2021-02-02
GeparX
GBG Forschungs GmbH
Phase 2 Completed
Clinical Trials
3 trialsNCT02879513 2020-03-23
Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant Chemotherapy
RenJi Hospital
Phase 3 Unknown
NCT02125344 2017-07-13
A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto)
GBG Forschungs GmbH
Phase 3 Completed